Global CGT CDMO Supply, Demand and Key Producers, 2024-2030

Description

The global CGT CDMO market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global CGT CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CGT CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of CGT CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CGT CDMO total market, 2019-2030, (USD Million)
Global CGT CDMO total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: CGT CDMO total market, key domestic companies and share, (USD Million)
Global CGT CDMO revenue by player and market share 2019-2024, (USD Million)
Global CGT CDMO total market by Type, CAGR, 2019-2030, (USD Million)
Global CGT CDMO total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global CGT CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include WuXi AppTec, OBiO, GenScript, Porton, Lonza, Pharmaron, Catalent, Thermo Fisher and Oxford Biomedica (OXB), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CGT CDMO market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global CGT CDMO Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global CGT CDMO Market, Segmentation by Type
    Immune Cells
    Stem Cells
    Viral Vectors
    Plasmid DNA

Global CGT CDMO Market, Segmentation by Application
    Pharmaceutical and Biotechnology Companies
    Research and Academic Institutions
    Hospital
    Others

Companies Profiled:
    WuXi AppTec
    OBiO
    GenScript
    Porton
    Lonza
    Pharmaron
    Catalent
    Thermo Fisher
    Oxford Biomedica (OXB)
    Asymchem
    Rentschler Biopharma
    Novartis

Key Questions Answered
1. How big is the global CGT CDMO market?
2. What is the demand of the global CGT CDMO market?
3. What is the year over year growth of the global CGT CDMO market?
4. What is the total value of the global CGT CDMO market?
5. Who are the major players in the global CGT CDMO market?

Table of Contents

1 Supply Summary
    1.1 CGT CDMO Introduction
    1.2 World CGT CDMO Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World CGT CDMO Total Market by Region (by Headquarter Location)
        1.3.1 World CGT CDMO Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States CGT CDMO Market Size (2019-2030)
        1.3.3 China CGT CDMO Market Size (2019-2030)
        1.3.4 Europe CGT CDMO Market Size (2019-2030)
        1.3.5 Japan CGT CDMO Market Size (2019-2030)
        1.3.6 South Korea CGT CDMO Market Size (2019-2030)
        1.3.7 ASEAN CGT CDMO Market Size (2019-2030)
        1.3.8 India CGT CDMO Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 CGT CDMO Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 CGT CDMO Major Market Trends

2 Demand Summary
    2.1 World CGT CDMO Consumption Value (2019-2030)
    2.2 World CGT CDMO Consumption Value by Region
        2.2.1 World CGT CDMO Consumption Value by Region (2019-2024)
        2.2.2 World CGT CDMO Consumption Value Forecast by Region (2025-2030)
    2.3 United States CGT CDMO Consumption Value (2019-2030)
    2.4 China CGT CDMO Consumption Value (2019-2030)
    2.5 Europe CGT CDMO Consumption Value (2019-2030)
    2.6 Japan CGT CDMO Consumption Value (2019-2030)
    2.7 South Korea CGT CDMO Consumption Value (2019-2030)
    2.8 ASEAN CGT CDMO Consumption Value (2019-2030)
    2.9 India CGT CDMO Consumption Value (2019-2030)

3 World CGT CDMO Companies Competitive Analysis
    3.1 World CGT CDMO Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global CGT CDMO Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for CGT CDMO in 2023
        3.2.3 Global Concentration Ratios (CR8) for CGT CDMO in 2023
    3.3 CGT CDMO Company Evaluation Quadrant
    3.4 CGT CDMO Market: Overall Company Footprint Analysis
        3.4.1 CGT CDMO Market: Region Footprint
        3.4.2 CGT CDMO Market: Company Product Type Footprint
        3.4.3 CGT CDMO Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: CGT CDMO Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: CGT CDMO Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: CGT CDMO Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: CGT CDMO Consumption Value Comparison
        4.2.1 United States VS China: CGT CDMO Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: CGT CDMO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based CGT CDMO Companies and Market Share, 2019-2024
        4.3.1 United States Based CGT CDMO Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies CGT CDMO Revenue, (2019-2024)
    4.4 China Based Companies CGT CDMO Revenue and Market Share, 2019-2024
        4.4.1 China Based CGT CDMO Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies CGT CDMO Revenue, (2019-2024)
    4.5 Rest of World Based CGT CDMO Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based CGT CDMO Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies CGT CDMO Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World CGT CDMO Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Immune Cells
        5.2.2 Stem Cells
        5.2.3 Viral Vectors
        5.2.4 Plasmid DNA
    5.3 Market Segment by Type
        5.3.1 World CGT CDMO Market Size by Type (2019-2024)
        5.3.2 World CGT CDMO Market Size by Type (2025-2030)
        5.3.3 World CGT CDMO Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World CGT CDMO Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical and Biotechnology Companies
        6.2.2 Research and Academic Institutions
        6.2.3 Hospital
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World CGT CDMO Market Size by Application (2019-2024)
        6.3.2 World CGT CDMO Market Size by Application (2025-2030)
        6.3.3 World CGT CDMO Market Size by Application (2019-2030)

7 Company Profiles
    7.1 WuXi AppTec
        7.1.1 WuXi AppTec Details
        7.1.2 WuXi AppTec Major Business
        7.1.3 WuXi AppTec CGT CDMO Product and Services
        7.1.4 WuXi AppTec CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 WuXi AppTec Recent Developments/Updates
        7.1.6 WuXi AppTec Competitive Strengths & Weaknesses
    7.2 OBiO
        7.2.1 OBiO Details
        7.2.2 OBiO Major Business
        7.2.3 OBiO CGT CDMO Product and Services
        7.2.4 OBiO CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 OBiO Recent Developments/Updates
        7.2.6 OBiO Competitive Strengths & Weaknesses
    7.3 GenScript
        7.3.1 GenScript Details
        7.3.2 GenScript Major Business
        7.3.3 GenScript CGT CDMO Product and Services
        7.3.4 GenScript CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 GenScript Recent Developments/Updates
        7.3.6 GenScript Competitive Strengths & Weaknesses
    7.4 Porton
        7.4.1 Porton Details
        7.4.2 Porton Major Business
        7.4.3 Porton CGT CDMO Product and Services
        7.4.4 Porton CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Porton Recent Developments/Updates
        7.4.6 Porton Competitive Strengths & Weaknesses
    7.5 Lonza
        7.5.1 Lonza Details
        7.5.2 Lonza Major Business
        7.5.3 Lonza CGT CDMO Product and Services
        7.5.4 Lonza CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Lonza Recent Developments/Updates
        7.5.6 Lonza Competitive Strengths & Weaknesses
    7.6 Pharmaron
        7.6.1 Pharmaron Details
        7.6.2 Pharmaron Major Business
        7.6.3 Pharmaron CGT CDMO Product and Services
        7.6.4 Pharmaron CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Pharmaron Recent Developments/Updates
        7.6.6 Pharmaron Competitive Strengths & Weaknesses
    7.7 Catalent
        7.7.1 Catalent Details
        7.7.2 Catalent Major Business
        7.7.3 Catalent CGT CDMO Product and Services
        7.7.4 Catalent CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Catalent Recent Developments/Updates
        7.7.6 Catalent Competitive Strengths & Weaknesses
    7.8 Thermo Fisher
        7.8.1 Thermo Fisher Details
        7.8.2 Thermo Fisher Major Business
        7.8.3 Thermo Fisher CGT CDMO Product and Services
        7.8.4 Thermo Fisher CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Thermo Fisher Recent Developments/Updates
        7.8.6 Thermo Fisher Competitive Strengths & Weaknesses
    7.9 Oxford Biomedica (OXB)
        7.9.1 Oxford Biomedica (OXB) Details
        7.9.2 Oxford Biomedica (OXB) Major Business
        7.9.3 Oxford Biomedica (OXB) CGT CDMO Product and Services
        7.9.4 Oxford Biomedica (OXB) CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Oxford Biomedica (OXB) Recent Developments/Updates
        7.9.6 Oxford Biomedica (OXB) Competitive Strengths & Weaknesses
    7.10 Asymchem
        7.10.1 Asymchem Details
        7.10.2 Asymchem Major Business
        7.10.3 Asymchem CGT CDMO Product and Services
        7.10.4 Asymchem CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Asymchem Recent Developments/Updates
        7.10.6 Asymchem Competitive Strengths & Weaknesses
    7.11 Rentschler Biopharma
        7.11.1 Rentschler Biopharma Details
        7.11.2 Rentschler Biopharma Major Business
        7.11.3 Rentschler Biopharma CGT CDMO Product and Services
        7.11.4 Rentschler Biopharma CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Rentschler Biopharma Recent Developments/Updates
        7.11.6 Rentschler Biopharma Competitive Strengths & Weaknesses
    7.12 Novartis
        7.12.1 Novartis Details
        7.12.2 Novartis Major Business
        7.12.3 Novartis CGT CDMO Product and Services
        7.12.4 Novartis CGT CDMO Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Novartis Recent Developments/Updates
        7.12.6 Novartis Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 CGT CDMO Industry Chain
    8.2 CGT CDMO Upstream Analysis
    8.3 CGT CDMO Midstream Analysis
    8.4 CGT CDMO Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World CGT CDMO Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World CGT CDMO Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World CGT CDMO Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World CGT CDMO Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World CGT CDMO Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World CGT CDMO Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World CGT CDMO Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World CGT CDMO Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World CGT CDMO Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key CGT CDMO Players in 2023
    Table 12. World CGT CDMO Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global CGT CDMO Company Evaluation Quadrant
    Table 14. Head Office of Key CGT CDMO Player
    Table 15. CGT CDMO Market: Company Product Type Footprint
    Table 16. CGT CDMO Market: Company Product Application Footprint
    Table 17. CGT CDMO Mergers & Acquisitions Activity
    Table 18. United States VS China CGT CDMO Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China CGT CDMO Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based CGT CDMO Companies, Headquarters (States, Country)
    Table 21. United States Based Companies CGT CDMO Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies CGT CDMO Revenue Market Share (2019-2024)
    Table 23. China Based CGT CDMO Companies, Headquarters (Province, Country)
    Table 24. China Based Companies CGT CDMO Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies CGT CDMO Revenue Market Share (2019-2024)
    Table 26. Rest of World Based CGT CDMO Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies CGT CDMO Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies CGT CDMO Revenue Market Share (2019-2024)
    Table 29. World CGT CDMO Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World CGT CDMO Market Size by Type (2019-2024) & (USD Million)
    Table 31. World CGT CDMO Market Size by Type (2025-2030) & (USD Million)
    Table 32. World CGT CDMO Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World CGT CDMO Market Size by Application (2019-2024) & (USD Million)
    Table 34. World CGT CDMO Market Size by Application (2025-2030) & (USD Million)
    Table 35. WuXi AppTec Basic Information, Area Served and Competitors
    Table 36. WuXi AppTec Major Business
    Table 37. WuXi AppTec CGT CDMO Product and Services
    Table 38. WuXi AppTec CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. WuXi AppTec Recent Developments/Updates
    Table 40. WuXi AppTec Competitive Strengths & Weaknesses
    Table 41. OBiO Basic Information, Area Served and Competitors
    Table 42. OBiO Major Business
    Table 43. OBiO CGT CDMO Product and Services
    Table 44. OBiO CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. OBiO Recent Developments/Updates
    Table 46. OBiO Competitive Strengths & Weaknesses
    Table 47. GenScript Basic Information, Area Served and Competitors
    Table 48. GenScript Major Business
    Table 49. GenScript CGT CDMO Product and Services
    Table 50. GenScript CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. GenScript Recent Developments/Updates
    Table 52. GenScript Competitive Strengths & Weaknesses
    Table 53. Porton Basic Information, Area Served and Competitors
    Table 54. Porton Major Business
    Table 55. Porton CGT CDMO Product and Services
    Table 56. Porton CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Porton Recent Developments/Updates
    Table 58. Porton Competitive Strengths & Weaknesses
    Table 59. Lonza Basic Information, Area Served and Competitors
    Table 60. Lonza Major Business
    Table 61. Lonza CGT CDMO Product and Services
    Table 62. Lonza CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Lonza Recent Developments/Updates
    Table 64. Lonza Competitive Strengths & Weaknesses
    Table 65. Pharmaron Basic Information, Area Served and Competitors
    Table 66. Pharmaron Major Business
    Table 67. Pharmaron CGT CDMO Product and Services
    Table 68. Pharmaron CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Pharmaron Recent Developments/Updates
    Table 70. Pharmaron Competitive Strengths & Weaknesses
    Table 71. Catalent Basic Information, Area Served and Competitors
    Table 72. Catalent Major Business
    Table 73. Catalent CGT CDMO Product and Services
    Table 74. Catalent CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Catalent Recent Developments/Updates
    Table 76. Catalent Competitive Strengths & Weaknesses
    Table 77. Thermo Fisher Basic Information, Area Served and Competitors
    Table 78. Thermo Fisher Major Business
    Table 79. Thermo Fisher CGT CDMO Product and Services
    Table 80. Thermo Fisher CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Thermo Fisher Recent Developments/Updates
    Table 82. Thermo Fisher Competitive Strengths & Weaknesses
    Table 83. Oxford Biomedica (OXB) Basic Information, Area Served and Competitors
    Table 84. Oxford Biomedica (OXB) Major Business
    Table 85. Oxford Biomedica (OXB) CGT CDMO Product and Services
    Table 86. Oxford Biomedica (OXB) CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Oxford Biomedica (OXB) Recent Developments/Updates
    Table 88. Oxford Biomedica (OXB) Competitive Strengths & Weaknesses
    Table 89. Asymchem Basic Information, Area Served and Competitors
    Table 90. Asymchem Major Business
    Table 91. Asymchem CGT CDMO Product and Services
    Table 92. Asymchem CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Asymchem Recent Developments/Updates
    Table 94. Asymchem Competitive Strengths & Weaknesses
    Table 95. Rentschler Biopharma Basic Information, Area Served and Competitors
    Table 96. Rentschler Biopharma Major Business
    Table 97. Rentschler Biopharma CGT CDMO Product and Services
    Table 98. Rentschler Biopharma CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Rentschler Biopharma Recent Developments/Updates
    Table 100. Novartis Basic Information, Area Served and Competitors
    Table 101. Novartis Major Business
    Table 102. Novartis CGT CDMO Product and Services
    Table 103. Novartis CGT CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 104. Global Key Players of CGT CDMO Upstream (Raw Materials)
    Table 105. CGT CDMO Typical Customers
List of Figure
    Figure 1. CGT CDMO Picture
    Figure 2. World CGT CDMO Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World CGT CDMO Total Market Size (2019-2030) & (USD Million)
    Figure 4. World CGT CDMO Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World CGT CDMO Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company CGT CDMO Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company CGT CDMO Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company CGT CDMO Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company CGT CDMO Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company CGT CDMO Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company CGT CDMO Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company CGT CDMO Revenue (2019-2030) & (USD Million)
    Figure 13. CGT CDMO Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World CGT CDMO Consumption Value (2019-2030) & (USD Million)
    Figure 16. World CGT CDMO Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States CGT CDMO Consumption Value (2019-2030) & (USD Million)
    Figure 18. China CGT CDMO Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe CGT CDMO Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan CGT CDMO Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea CGT CDMO Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN CGT CDMO Consumption Value (2019-2030) & (USD Million)
    Figure 23. India CGT CDMO Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of CGT CDMO by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for CGT CDMO Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for CGT CDMO Markets in 2023
    Figure 27. United States VS China: CGT CDMO Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: CGT CDMO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World CGT CDMO Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World CGT CDMO Market Size Market Share by Type in 2023
    Figure 31. Immune Cells
    Figure 32. Stem Cells
    Figure 33. Viral Vectors
    Figure 34. Plasmid DNA
    Figure 35. World CGT CDMO Market Size Market Share by Type (2019-2030)
    Figure 36. World CGT CDMO Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World CGT CDMO Market Size Market Share by Application in 2023
    Figure 38. Pharmaceutical and Biotechnology Companies
    Figure 39. Research and Academic Institutions
    Figure 40. Hospital
    Figure 41. Others
    Figure 42. CGT CDMO Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Companies Mentioned

WuXi AppTec
OBiO
GenScript
Porton
Lonza
Pharmaron
Catalent
Thermo Fisher
Oxford Biomedica (OXB)
Asymchem
Rentschler Biopharma
Novartis